INBX
Price
$34.30
Change
+$0.26 (+0.76%)
Updated
May 1, 6:59 PM EST
5 days until earnings call
KYMR
Price
$36.20
Change
+$2.57 (+7.64%)
Updated
May 1, 6:59 PM EST
One day until earnings call
Ad is loading...

Compare predictions INBX vs KYMR

Header iconINBX vs KYMR Comparison
Open Charts INBX vs KYMRBanner chart's image
Inhibrx
Price$34.30
Change+$0.26 (+0.76%)
Volume$358.06K
CapitalizationN/A
Kymera Therapeutics
Price$36.20
Change+$2.57 (+7.64%)
Volume$362.26K
CapitalizationN/A
View a ticker or compare two or three
INBX vs KYMR Comparison Chart

Loading...

INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KYMRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
INBX vs. KYMR commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and KYMR is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (INBX: $34.04 vs. KYMR: $33.62)
Brand notoriety: INBX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 40% vs. KYMR: 78%
Market capitalization -- INBX: $1.63B vs. KYMR: $2.22B
INBX [@Biotechnology] is valued at $1.63B. KYMR’s [@Biotechnology] market capitalization is $2.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both INBX and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INBX is a better buy in the short-term than KYMR.

Price Growth

INBX (@Biotechnology) experienced а -0.26% price change this week, while KYMR (@Biotechnology) price change was -5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

INBX is expected to report earnings on Aug 05, 2024.

KYMR is expected to report earnings on Aug 02, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for INBX with price predictions.
OPEN
A.I.dvisor published
a Summary for KYMR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KYMR($2.22B) has a higher market cap than INBX($1.63B). KYMR YTD gains are higher at: 32.050 vs. INBX (-10.421).
INBXKYMRINBX / KYMR
Capitalization1.63B2.22B73%
EBITDAN/AN/A-
Gain YTD-10.42132.050-33%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
INBXKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KYMRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPDX43.83-0.27
-0.61%
Rydex Consumer Products A
GQRPX18.65-0.15
-0.80%
GQG Partners Global Quality Equity Inv
AFOIX15.07-0.24
-1.57%
Alger Mid Cap Focus I
IPLSX26.74-0.47
-1.73%
Voya Index Plus LargeCap Port S
FSPGX31.47-0.57
-1.78%
Fidelity Large Cap Growth Idx

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-0.35%
AXON - INBX
48%
Loosely correlated
+0.11%
AKRO - INBX
44%
Loosely correlated
+1.38%
PCVX - INBX
42%
Loosely correlated
-0.79%
SNTI - INBX
39%
Loosely correlated
+16.24%
RAPT - INBX
38%
Loosely correlated
-2.28%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with INBX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.00%
INBX - KYMR
47%
Loosely correlated
-0.35%
ARVN - KYMR
45%
Loosely correlated
-0.41%
DYN - KYMR
44%
Loosely correlated
-0.59%
EDIT - KYMR
43%
Loosely correlated
-2.98%
AXON - KYMR
42%
Loosely correlated
+0.11%
More